Results 241 to 250 of about 252,929 (281)

In‐Depth Profiling Highlights the Effect of Efgartigimod on Peripheral Innate and Adaptive Immune Cells in Myasthenia Gravis

open access: yesAnnals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Background Myasthenia gravis (MG) is an autoimmune disorder characterized by antibody‐mediated complement activation. Efgartigimod, a neonatal Fc receptor (FcRn) antagonist, is approved for treating generalized MG (gMG). However, its modulatory effects on upstream innate and adaptive immune cells remain largely unexplored.
Lei Jin   +11 more
wiley   +1 more source

Autism Spectrum Disorder and Co-occurring Substance Use Disorder – A Systematic Review

open access: yesSubstance Abuse: Research and Treatment, 2016
Espen Ajo Arnevik   +1 more
doaj  

Prevalence of substance use disorder in individuals with attention deficit/hyperactivity disorder: associations with sex and psychiatric comorbidity. [PDF]

open access: yesBMC Psychiatry
Moldekleiv CD   +6 more
europepmc   +1 more source

Examining Vaping Policies in Substance Use Disorder Treatment Facilities. [PDF]

open access: yesTob Use Insights
Ware OD   +3 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy